WEIGHT LOSS Web Results

Eli Lilly Says Retatrutide Shows More Weight Loss Compared to ... Lilly's experimental retatrutide produced more than twice the weight loss of Ozempic in a head-to-head diabetes trial—but more patients stopped treatment because of side effects. In Lilly's Phase 3 trial, retatrutide lowered A1C and body weight more than Ozempic 2 mg in adults with type 2 diabetes, but caused more treatment discontinuations.

Illinois Gov. JB Pritzker Says He Has Lost 80 Pounds on ‘Life-Changing ... Gov. JB Pritzker discloses diabetes diagnosis, 80-pound weight loss on GLP-1 drug Gov. JB Pritzker disclosed Monday that he was diagnosed with type 2 diabetes two years ago and has since lost 80 pounds using a GLP-1 drug.

Ozempic may be reshaping the brain, scientists say - Ground News A new NIH-funded study published in Nature on May 6 reveals that oral GLP-1 weight-loss drugs target a deep-brain reward circuit, dampening 'hedonic feeding'—eating motivated by pleasure rather than hunger. Researchers found these oral compounds activate the central amygdala, a brain region tied ...

New Jersey Man Loses 9 Pounds After Eating Only Sweetgreen for 25 Days New Jersey man loses weight after eating nothing but meals from a high-end chain for 25 days A New Jersey man ate nothing but certain foods from a fast-casual chain for 25 days — an experiment that left him nine pounds lighter and craving a slice of pizza.

Weight loss drugs linked to increased risk of hair loss, researchers say Recent studies reveal a higher risk of hair loss for patients using GLP-1 drugs for diabetes and obesity treatment compared to other medications. While the occurrence rate is relatively low, the odds are notably higher with drugs like semaglutide and tirzepatide. Potential factors beyond weight loss could influence this side effect.

Eli Lilly's experimental weight loss drug shed 21% of body weight in ... New weight loss drug shows major results in two new studies In a trial of people with obesity, participants on the top dose lost about 25% of their body weight. That's about 60 pounds for a 250-pound person.

US judge refuses to block Eli Lilly weight-loss drug ads, rules against ... A US judge rejected on Monday Novo Nordisk's request to block Eli ‌Lilly from continuing advertisements for weight-loss drugs that the Danish drugmaker considered false and misleading, affecting markets with tens of billions of dollars of annual sales.

GLP-1 Makers Sued Over Rare Sudden Vision Loss - Ground News Hundreds of Americans have filed personal injury lawsuits against the makers of GLP-1 drugs such as Ozempic, Wegovy and Mounjaro, alleging they were not adequately warned about the increased risk of a rare form of sudden vision loss known as NAION associated with the weight-loss treatment.

Women More Often Hired After Losing Weight on GLP-1s: Study A recent study shows women who are on GLP-1s weren’t just losing weight but also increasing their chances of getting hired at a new job.

GLP-1 Drugs Show Potential Anti-Aging Benefits, but More Research Is Needed New research suggests the diabetes and weight-loss drugs may reduce biological age by 2 to 4 years, while studies also link them to hair loss ...